Decision

The Reserve Bank of New Zealand kept interest rates unchanged but raised its forecasts for future interest rates. This was more stringent and sent the NZD/USD pair higher. But after reaching the swing zone resistance between 0.6148 and…

EUR/NZD is approaching the technical resistance area! Will the pair continue its downward trend this week? Or will the RBNZ policy decision inspire a bullish breakout for its Kiwi counterpart? While we did not see market catalysts…

With inflation remaining hotter than desired in the first quarter of 2024, the Fed's first expected interest rate cut in more than four years continues to push through later in the calendar, with some wondering whether the central…

High risk warning: Foreign exchange trading involves a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before…

Basic overviewThe US dollar has weakened across the board recently due to a more dovish than expected FOMC decision last week as the Fed decided to signal a further tapering of the QT period starting in June and Fed Chairman Powell…

The US Securities and Exchange Commission (SEC) has postponed its decision on whether or not to approve the proposed Invesco Galaxy exchange-traded fund (ETF) product for a third time. With the latest delay, the agency has…

I've always been very critical of Starbucks (SBUX).I remember working for the company as a stock analyst and spending weeks inside its stores studying the workflow in each department. It was an extreme exercise that won me no fans…

Written by Alun JohnLONDON (Reuters) - The dollar rose towards its highest levels this year against a basket of its counterparts and US stock futures fell on Wednesday ahead of the Federal Reserve’s monetary policy decision, although…

Over the past 24 hours, Ethereum (ETH), the second-largest cryptocurrency by market cap, has seen a significant 5% rise. prices drop. The decline comes amid growing speculation that the highly anticipated ETFs…

The African CDC has faulted US biotech firm Moderna for halting its plans to set up a vaccine manufacturing plant in Kenya. In a statement released on Monday, the African CDC expressed disappointment at Moderna's move, claiming that…